Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Investing Activities: 2020-2024

Historic Cash from Investing Activities for Therapeutics (LENZ) over the last 5 years, with Dec 2024 value amounting to -$154.5 million.

  • Therapeutics' Cash from Investing Activities rose 12.19% to $15.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$29.6 million, marking a year-over-year increase of 87.75%. This contributed to the annual value of -$154.5 million for FY2024, which is 421.52% down from last year.
  • Therapeutics' Cash from Investing Activities amounted to -$154.5 million in FY2024, which was down 421.52% from -$29.6 million recorded in FY2023.
  • Therapeutics' 5-year Cash from Investing Activities high stood at -$1.5 million for FY2020, and its period low was -$241.9 million during FY2022.
  • Over the past 3 years, Therapeutics' median Cash from Investing Activities value was -$154.5 million (recorded in 2024), while the average stood at -$142.0 million.
  • Per our database at Business Quant, Therapeutics' Cash from Investing Activities crashed by 4,113.64% in 2022 and then surged by 87.75% in 2023.
  • Yearly analysis of 5 years shows Therapeutics' Cash from Investing Activities stood at -$1.5 million in 2020, then plummeted by 271.52% to -$5.7 million in 2021, then crashed by 4,113.64% to -$241.9 million in 2022, then skyrocketed by 87.75% to -$29.6 million in 2023, then plummeted by 421.52% to -$154.5 million in 2024.